[VRTX] QoQ Quarter Result on 30-Jun-2024 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
02-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -426.81%
YoY- -492.44%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 2,771,900 2,634,700 2,687,200 2,517,700 2,483,500 2,493,200 2,374,800 10.82%
PBT 1,224,100 -3,391,200 1,279,100 1,147,600 1,179,200 1,161,500 891,500 23.46%
Tax 178,700 202,400 179,500 178,800 143,900 245,800 191,700 -4.56%
NP 1,045,400 -3,593,600 1,099,600 968,800 1,035,300 915,700 699,800 30.58%
Tax Rate -14.60% - -14.03% -15.58% -12.20% -21.16% -21.50% -
Total Cost 1,726,500 6,228,300 1,587,600 1,548,900 1,448,200 1,577,500 1,675,000 2.03%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 37.71 -136.40 40.92 38.48 41.69 36.73 29.47 17.81%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 4.05 -13.92 4.26 3.76 4.01 3.55 2.72 30.29%
EPS Diluted 4.01 -13.92 4.21 3.71 3.97 3.52 2.69 30.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.